Treatment of Modified Wumei Pills on 40 Cases with Ventricular Premature Systole of Coronary Heart Disease

WU Jian-guang; LAI Jun-yu

doi:10.13422/j.cnki.syfjx.2014220212

您当前的位置：

首页 >

文章列表页 >

Treatment of Modified Wumei Pills on 40 Cases with Ventricular Premature Systole of Coronary Heart Disease

更新时间：2024-01-04

- Treatment of Modified Wumei Pills on 40 Cases with Ventricular Premature Systole of Coronary Heart Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 22, Pages: 212-215(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014220212
  CLC： R259
- Published：2014
- 稿件说明：
移动端阅览
WU Jian-guang, LAI Jun-yu. Treatment of Modified Wumei Pills on 40 Cases with Ventricular Premature Systole of Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(22): 212-215.
DOI：

WU Jian-guang, LAI Jun-yu. Treatment of Modified Wumei Pills on 40 Cases with Ventricular Premature Systole of Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(22): 212-215. DOI： 10.13422/j.cnki.syfjx.2014220212.

摘要

目的: 观察乌梅丸加减治疗冠心病室性早搏的疗效及对患者心率变异性(HRV)的影响.方法: 80例冠心病室性早搏患者采用随机按数字表法分为对照组和观察组各40例.对照组采用盐酸胺碘酮片治疗

观察组在对照组治疗的基础上加服乌梅丸加减治疗

两组疗程均为4周.采用24 h动态心电图记录室性早搏的变化情况及心率变异性(HRV)

记录心悸、胸闷、胸痛、气短等症状评分

治疗前后各评价1次.结果: 经Ridit分析

观察组室性早搏疗效优于对照组(P<0.05)

观察组冠心病心电图疗效优于对照组(P<0.05);治疗后观察组心悸、胸闷、胸痛、气短等症状评分及总分均低于对照组(P<0.01);治疗后两组HRV各参数指标:正常R-R间期标准差(SDNN)

24 h 每5 min平均正常的R-R间期的标准差(SDANN)、相邻正常R-R间期差值的均方根(RMSSD)

相邻正常R-R间期差值≥50 ms的心搏数占总R-R间期数的百分数(PNN50)均较治疗前有所上升(P<0.01)

观察组HRV各参数提高程度均优于对照组(P<0.01);治疗后观察组室性早搏数少于对照组(P<0.01).结论: 乌梅丸加减治疗冠心病室性早搏能减少室性早搏数

减轻临床症状

改善HRV各参数

对室性早搏和冠心病均有一定疗效.

Abstract

Objective:To observe curative efficacy and influence on heart rate variability (HRV) of modified Wumei pills in treating patients with ventricular premature systole of coronary heart disease (VPSCHD). Method: Eighty patients with VPSCHD were randomly divided into control group (40 cases) and observation group (40 cases) by random number table. Patients in control group received amiodarone hydrochloride tablets. Based on the treatment in control group

patients in observation group added modified Wumei pills. The patients received 1 4-week periods of treatment. Before and after treatment

changes of ventricular premature beat and HRV were recorded by 24-hourdynamic electrocardiogram

and scores of palpitation

choking sensation in chest

chest pain and breathe hard were graded once before and after treatment. Result: The ventricular premature beat effect of observation group was superior to that of control group (P<0.05)

and the electrocardiogram effect of coronary heart disease was better than that of control group (P<0.05) through ridit analysis. Symptom scores of heart palpitations

chest tightness

chest pain

shortness of breath and the total score in observation group were lower than those in control group after treatment (P<0.01). HRV parameters in both groups including standard deviation of normal number of intervals

each sequential 5-min R-R interval standard deviation during 24 h period

the root mean square difference of adjacent normal R-R interval and the percentage of phase difference between adjacent normal R-R was ≥50 ms heart beat being occupied the total R-R were higher after the treatment (P<0.01). The improvement of HRV parameters in observation group was superior to that in control group (P<0.01)

and the number of ventricular premature beat in observation group was less than that in control group (P<0.01). Conclusion: Modified Wumei pills could reduce number of ventricular premature beat

relieve clinical symptoms

and improve HRV parameters in patients with VPSCHD. It has certain curative effect on both ventricular premature beat and coronary heart disease.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Tongguan Fumai Decoction to Treat Ventricular Premature Beat in Coronary Heart Disease of 38 Cases

Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics

Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation

Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway

Construction of an Intelligent Diagnosis and Treatment Ontology for Traditional Chinese Medicine Based on Clinical Practice Guidelines：A Case Study of Coronary Heart Disease

Related Author

YAN Ming-ying

DENG Zhi

XU De-wei

JIANG Yu

HU Longxiao

GAO Jiabei

MA Weihao

LU Jieming

Related Institution

Natural History Museum of China

Beijing Key Laboratory of Chinese Materia Pharmacology，National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences

School of Clinical Medicine，Beijing University of Chinese Medicine

Institute of Basic Medical Sciences，Xiyuan Hospital，China Academy of Chinese Medical Sciences

Hunan Traditional Chinese Medical College

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰